Viewing StudyNCT00036296

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00036296
Status: COMPLETED
Last Update Posted: 2011-04-13
First Post: 2002-05-08
Brief Title: Effects of Talampanel on Patients With Advanced Parkinsons Disease
Sponsor: Teva Branded Pharmaceutical Products RD Inc
Organization: Teva Branded Pharmaceutical Products RD Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Movement Disorders
Dyskinesias
Parkinson Disease
Keywords:
Name View
Levodopa induced dyskinesia View
Involuntary Movements View
Abnormal Movements View
Advanced Parkinsons disease View